Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides.
Antisense oligonucleotides (ODNs) with base sequences complementary to a specific RNA can, after binding to intracellular mRNA, selectively modulate the expression of a gene. However, these molecules are poorly stable in biological fluids and are characterized by a low intracellular penetration. In view of using ODNs as active molecules, the development of nanocapsules containing ODNs in their aqueous core was considered. Nanocapsules were prepared by interfacial polymerization of isobutylcyanoacrylate (IBCA) in a W/O emulsion. After ultracentrifugation and re-suspension in water, the nanocapsules displayed a size of 350+/-100 nm. Oligonucleotide loading did not significantly influence the zeta potential, suggesting that they were located within the core of the nanocapsules. Fluorescence quenching assays confirmed this localization. When encapsulated in the nanocapsules and incubated in the presence of serum, the ODNs were efficiently protected from degradation by nucleases, whereas ODNs adsorbed onto nanospheres were less efficiently protected. This paper describes, for the first time, a nanotechnology able to encapsulate ODNs, rather than adsorbing them at the surface of a solid support. Such a formulation has great potential for oligonucleotide delivery.
Lambert
G
G
Laboratoire de Physico-chimie, Pharmacotechnie et Biopharmacie, UMR CNRS 8612, Faculté de Pharmacie, 92290 Chatenay-Malabry, France.
Fattal
E
E
Pinto-Alphandary
H
H
Gulik
A
A
Couvreur
P
P
D003487:Cyanoacrylates / Q000008:administration & dosage*; D004337:Drug Carriers; D004355:Drug Stability; D004655:Emulsions; D004659:Enbucrilate; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage*; D011108:Polymers / Q000008:administration & dosage*
D003487:Cyanoacrylates; D004337:Drug Carriers; D004655:Emulsions; D016376:Oligonucleotides, Antisense; D011108:Polymers; D004659:Enbucrilate